These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4978633)

  • 1. [A study of the antigenic structure of typhoid monovaccine by the gel diffusion method].
    Bentsianova TG
    Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):51-6. PubMed ID: 4978633
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of the antigenic structure of the typhoid component of typho-paratyphoid B divaccine tested in epidemiologic trial No. 5 (1962)].
    Bentsianova TG
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Dec; 44(12):43-7. PubMed ID: 4978642
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoelectrophoretic analysis of the antigenic composition of typhoid vaccines with established effectiveness].
    Bentsianova TG; Kheĭfets LB
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jan; 46(1):40-6. PubMed ID: 5787570
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the O antigen in typhoid vaccines by means of the metachromatic reaction].
    Grodecka B; Schiller B
    Med Dosw Mikrobiol; 1966; 18(3):237-45. PubMed ID: 5913959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of O and Vi antigens in corpuscular typhoid vaccines with the use of the hemagglutination inhibition reaction].
    Aleksandrova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):60-6. PubMed ID: 5662251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antigen Vi content in typhoid vaccines used for epidemiologic experiments in the USSR in 1961].
    Taylor A; Bencjanowa TG
    Przegl Epidemiol; 1968; 22(1):57-69. PubMed ID: 5669176
    [No Abstract]   [Full Text] [Related]  

  • 7. CHARACTERIZATION OF HUMAN ANTIBODIES TO SALMONELLA TYPHI BY GEL-FILTRATION AND ANTIGENIC ANALYSIS.
    TURNER MW; ROWE DS
    Immunology; 1964 Nov; 7(6):639-56. PubMed ID: 14239839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Design of new types of chemical vaccines for the prevention of intestinal infections and problems of their qualitative evaluation. Report 2. Immunochemical characteristics of the experimental preparations].
    Vasil'eva TG; Shapiro NI; Sazonets GI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):29-34. PubMed ID: 1221723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of laboratory testing of the reactivity of various typhoid vaccines compared with the observation data in man].
    Melikova EN; Lesniak SV; Koval'skaia SIa
    Zh Mikrobiol Epidemiol Immunobiol; 1968; 45(10):119-24. PubMed ID: 5731556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of the new chemical sorbed typhoid monovaccine P in a strictly controlled experiment].
    Karpukhin GI; Andrievskaia RA; Shapiro NI; Luk'ianova EG; Belaia GN
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (3):81-6. PubMed ID: 785908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective activity of various antigen complexes of typhoid and paratyphoid B vaccines: controlled field trials and laboratory studies.
    Hejfets LB; Levina LA; Bentsianova TG; Salmin LV
    Prog Immunobiol Stand; 1970; 4():561-70. PubMed ID: 4991591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of preparations of typhoid antigens obtained by ultrafiltration].
    Khokholev LS; Shapiro NI; Katalevskiĭ EE
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):81-4. PubMed ID: 7234247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with the treatment of typhoid fever with levomycetin and typhoid monovaccine].
    STARSHINOVA VS
    Sov Med; 1961 Dec; 25():64-9. PubMed ID: 13916379
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-immunological characteristics of the results of treatment of patients with typhoid by a complex method using VI-antigen, monovaccine, and levomycetin].
    Bunin KV; Deriagin IuP
    Sov Med; 1974 May; 37(5):8-12. PubMed ID: 4832529
    [No Abstract]   [Full Text] [Related]  

  • 15. [Production of typhoid vaccine by the Zagreb method].
    Sańchez PE; Galicia AO
    Salud Publica Mex; 1981; 23(6):641-7. PubMed ID: 7336287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined treatment of patients with typhoid with levomycetin, apilar, typhoid monovaccine and total ultraviolet irradiation].
    Normanskiĭ ES; Ivanovskaia KN; Koshkin AI; Podlevskiĭ AF
    Antibiotiki; 1966 May; 11(5):471-5. PubMed ID: 5993094
    [No Abstract]   [Full Text] [Related]  

  • 17. [The presence of a hypothetical extracellular fraction in integral typhoid vaccines prepared on a semi-synthetic medium (author's transl)].
    Loggini F; Milici G; Grillo OC
    Ann Sclavo; 1977; 19(3):464-9. PubMed ID: 607886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dynamics of Vi-antibodies of different classes in typhoid patients during their treatment with levomycetin combined with alcoholic monovaccine and Vi-antigen].
    Sukhoroslova LI; Deriagin IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):15-8. PubMed ID: 4787689
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE EFFECT OF IMMUNIZATION WITH TYPHOID MONOVACCINE ON THE BACTERICIDAL PROPERTIES OF RABBIT SKIN].
    MALYSHEV FS
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Oct; 40():80-4. PubMed ID: 14134935
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parathyphoid B-antigen containing a complex of protective surface antigens].
    Stepanova LK; Sergeeva NS; Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Nov; (11):41-7. PubMed ID: 103345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.